Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)

24 Sept 2017

Abstract excerpt

// Bela Ozsvari 1,2 , Federica Sotgia 1,2 , Katie Simmons 3 , Rachel Trowbridge 3 , Richard Foster 3,4 and Michael P. Lisanti 1,2 1 Translational Medicine, School of Environment & Life Sciences, University of Salford, Greater Manchester, UK 2 The Paterson Institute, University of Manchester, Withington, UK 3 School of Molecular & Cellular Biology & Astbury Centre for Structural Molecular Biology, Faculty of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Diet and metabolism studies
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29108233
DOI: 10.18632/oncotarget.21259

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs)PMID 29108233Read ↗

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibitionSemantic proximity Read ↗

Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancerSemantic proximity Read ↗

Ketone body utilization drives tumor growth and metastasisSemantic proximity Read ↗

Hallmarks of cancer stem cell metabolismSemantic proximity Read ↗

The nutritional phenome of EMT-induced cancer stem-like cells.Semantic proximity Read ↗

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial EnergySemantic proximity Read ↗

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistantSemantic proximity Read ↗

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious diseaseSemantic proximity Read ↗

Targeted Anti-Mitochondrial Therapy: The Future of OncologySemantic proximity Read ↗

Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers.Semantic proximity Read ↗

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signalingSemantic proximity Read ↗

Targeting cancer stem cells from a metabolic perspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.